Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Proteins found to promote neuroinflammation in MS

Aug. 9, 2021

Targeting synaptogyrin-3 can ameliorate cognitive deficits

Aug. 9, 2021

Clene provides topline data from REPAIR-PD and REPAIR-MS studies

Aug. 6, 2021

INPP5D inhibition reduces amyloid pathology in Alzheimer's disease model

Aug. 6, 2021

Noema studies PDE10A inhibitor NOE-105 for Tourette's syndrome in phase IIa

Aug. 5, 2021

Updated results provided for ACI-24 in adults with Down syndrome

Aug. 5, 2021

Target engagement, safety seen with anti-TREM-2 monoclonal antibody AL-002 in healthy subjects

Aug. 5, 2021

GB-5001 demonstrates safety in toxicity study in dogs

Aug. 5, 2021

Lumosa reports phase IIa data on LT-3001 in patients after acute ischemic stroke

Aug. 4, 2021

ALZ-201 neutralizes the neurotoxicity of postmortem brain extracts from patients with AD

Aug. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...